DOCCHECK AG (AJ91.DE) Fundamental Analysis & Valuation

FRA:AJ91 • DE000A1A6WE6

12.2 EUR
0 (0%)
Last: Mar 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This AJ91.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to AJ91. AJ91 was compared to 12 industry peers in the Health Care Technology industry. AJ91 has an excellent financial health rating, but there are some minor concerns on its profitability. AJ91 is not valued too expensively and it also shows a decent growth rate. AJ91 also has an excellent dividend rating. This makes AJ91 very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

6

1. AJ91.DE Profitability Analysis

1.1 Basic Checks

  • AJ91 had positive earnings in the past year.
  • In the past year AJ91 had a positive cash flow from operations.
  • AJ91 had positive earnings in each of the past 5 years.
  • AJ91 had a positive operating cash flow in each of the past 5 years.
AJ91.DE Yearly Net Income VS EBIT VS OCF VS FCFAJ91.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

  • With a decent Return On Assets value of 9.09%, AJ91 is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 13.18%, AJ91 belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 8.86%, AJ91 is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for AJ91 is in line with the industry average of 8.30%.
Industry RankSector Rank
ROA 9.09%
ROE 13.18%
ROIC 8.86%
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
AJ91.DE Yearly ROA, ROE, ROICAJ91.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 9.82%, AJ91 is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • AJ91's Profit Margin has been stable in the last couple of years.
  • AJ91's Operating Margin of 12.33% is fine compared to the rest of the industry. AJ91 outperforms 66.67% of its industry peers.
  • In the last couple of years the Operating Margin of AJ91 has declined.
  • AJ91 has a better Gross Margin (79.18%) than 75.00% of its industry peers.
  • In the last couple of years the Gross Margin of AJ91 has remained more or less at the same level.
Industry RankSector Rank
OM 12.33%
PM (TTM) 9.82%
GM 79.18%
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
AJ91.DE Yearly Profit, Operating, Gross MarginsAJ91.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. AJ91.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AJ91 is still creating some value.
  • AJ91 has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AJ91 has more shares outstanding
  • Compared to 1 year ago, AJ91 has an improved debt to assets ratio.
AJ91.DE Yearly Shares OutstandingAJ91.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
AJ91.DE Yearly Total Debt VS Total AssetsAJ91.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 4.37 indicates that AJ91 is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of AJ91 (4.37) is better than 75.00% of its industry peers.
  • AJ91 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.37
ROIC/WACC1.25
WACC7.08%
AJ91.DE Yearly LT Debt VS Equity VS FCFAJ91.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

  • AJ91 has a Current Ratio of 2.74. This indicates that AJ91 is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of AJ91 (2.74) is better than 75.00% of its industry peers.
  • AJ91 has a Quick Ratio of 2.50. This indicates that AJ91 is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of AJ91 (2.50) is better than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 2.5
AJ91.DE Yearly Current Assets VS Current LiabilitesAJ91.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. AJ91.DE Growth Analysis

3.1 Past

  • AJ91 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 133.18%, which is quite impressive.
  • The Earnings Per Share has been growing by 10.57% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 0.69% in the past year.
  • The Revenue has been growing by 10.68% on average over the past years. This is quite good.
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AJ91.DE Yearly Revenue VS EstimatesAJ91.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

Find the best growth stocksShow best growing peers

5

4. AJ91.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.73, the valuation of AJ91 can be described as very reasonable.
  • AJ91's Price/Earnings ratio is rather cheap when compared to the industry. AJ91 is cheaper than 91.67% of the companies in the same industry.
  • AJ91's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.25.
Industry RankSector Rank
PE 11.73
Fwd PE N/A
AJ91.DE Price Earnings VS Forward Price EarningsAJ91.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AJ91 is valued cheaper than 91.67% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of AJ91 indicates a rather cheap valuation: AJ91 is cheaper than 83.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.51
EV/EBITDA 3.83
AJ91.DE Per share dataAJ91.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • AJ91 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.11
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. AJ91.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.95%, AJ91 is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.10, AJ91 pays a better dividend. On top of this AJ91 pays more dividend than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, AJ91 pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.95%

5.2 History

  • The dividend of AJ91 has a limited annual growth rate of 4.52%.
Dividend Growth(5Y)4.52%
Div Incr Years1
Div Non Decr Years1
AJ91.DE Yearly Dividends per shareAJ91.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 48.02% of the earnings are spent on dividend by AJ91. This is a bit on the high side, but may be sustainable.
  • The dividend of AJ91 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP48.02%
EPS Next 2YN/A
EPS Next 3YN/A
AJ91.DE Yearly Income VS Free CF VS DividendAJ91.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M
AJ91.DE Dividend Payout.AJ91.DE Dividend Payout, showing the Payout Ratio.AJ91.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

AJ91.DE Fundamentals: All Metrics, Ratios and Statistics

DOCCHECK AG

FRA:AJ91 (3/10/2026, 7:00:00 PM)

12.2

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)09-20
Earnings (Next)N/A
Inst Owners7.92%
Inst Owner ChangeN/A
Ins Owners71.92%
Ins Owner ChangeN/A
Market Cap61.85M
Revenue(TTM)53.79M
Net Income(TTM)5.28M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.95%
Yearly Dividend0.5
Dividend Growth(5Y)4.52%
DP48.02%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.73
Fwd PE N/A
P/S 1.15
P/FCF 9.51
P/OCF 8.1
P/B 1.54
P/tB 1.55
EV/EBITDA 3.83
EPS(TTM)1.04
EY8.52%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.28
FCFY10.52%
OCF(TTM)1.51
OCFY12.35%
SpS10.61
BVpS7.91
TBVpS7.87
PEG (NY)N/A
PEG (5Y)1.11
Graham Number13.6
Profitability
Industry RankSector Rank
ROA 9.09%
ROE 13.18%
ROCE 14.96%
ROIC 8.86%
ROICexc 17.58%
ROICexgc 17.72%
OM 12.33%
PM (TTM) 9.82%
GM 79.18%
FCFM 12.1%
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
ROICexc(3y)16.17%
ROICexc(5y)32.75%
ROICexgc(3y)16.36%
ROICexgc(5y)34.31%
ROCE(3y)15.72%
ROCE(5y)25.61%
ROICexgc growth 3Y-26.82%
ROICexgc growth 5Y-2.82%
ROICexc growth 3Y-26.26%
ROICexc growth 5Y-1.57%
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
F-Score6
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 45.88%
Cap/Sales 2.11%
Interest Coverage 250
Cash Conversion 83.94%
Profit Quality 123.15%
Current Ratio 2.74
Quick Ratio 2.5
Altman-Z 4.37
F-Score6
WACC7.08%
ROIC/WACC1.25
Cap/Depr(3y)102.11%
Cap/Depr(5y)131.26%
Cap/Sales(3y)5.41%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y86.96%
EBIT growth 3Y-26.09%
EBIT growth 5Y7.66%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.74%
FCF growth 3Y-1.99%
FCF growth 5Y54.46%
OCF growth 1Y1.69%
OCF growth 3Y-11.25%
OCF growth 5Y33.53%

DOCCHECK AG / AJ91.DE FAQ

Can you provide the ChartMill fundamental rating for DOCCHECK AG?

ChartMill assigns a fundamental rating of 6 / 10 to AJ91.DE.


What is the valuation status of DOCCHECK AG (AJ91.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to DOCCHECK AG (AJ91.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for DOCCHECK AG?

DOCCHECK AG (AJ91.DE) has a profitability rating of 6 / 10.


What is the financial health of DOCCHECK AG (AJ91.DE) stock?

The financial health rating of DOCCHECK AG (AJ91.DE) is 8 / 10.